A REDOX-BASED SYSTEM THAT ENHANCES DELIVERY OF ESTRADIOL TO THE BRAIN - PHARMACOKINETIC EVALUATION IN THE DOG

被引:9
作者
DIETZEL, K
KEUTH, V
ESTES, KS
BREWSTER, ME
CLEMMONS, RM
VISTELLE, R
BODOR, NS
DERENDORF, H
机构
[1] UNIV FLORIDA,COLL PHARM,DEPT PHARMACEUT,BOX J-494,GAINESVILLE,FL 32610
[2] UNIV FLORIDA,COLL PHARM,CTR DRUG DESIGN & DELIVERY,GAINESVILLE,FL 32610
[3] UNIV FLORIDA,COLL VET MED,GAINESVILLE,FL 32610
关键词
blood–brain barrier; brain enhanced drug delivery; chemical delivery system; estradiol; pharmacokinetics; redox drug delivery;
D O I
10.1023/A:1015977319212
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The pharmacokinetics of a dihydropyridine–pyridinium salt-type chemical delivery system (CDS) for brain-targeted delivery of estradiol (E2) were examined in dogs. Parameters evaluated in vitro included stability in buffers and biological fluids and plasma protein binding. In vivo studies examined drug and metabolite concentrations in plasma, urine, and cerebrospinal fluid as well as in selected brain regions. The administered lipophilic E2-CDS disappeared very quickly from plasma and was not detected in urine. The oxidized drug form, E2-Q+, was excreted unchanged or as a conjugate in the urine for as long as 2 weeks. Plasma levels were below assay detection limits at later times. Pharmacokinetic analysis of urine E2-Q+ levels allowed estimation of a half-life of 2.2 days. Amounts of E2-Q+ excreted into the urine were proportional to the dose but averaged only 13.9% of the dose, indicating that other routes of excretion must be considered. CSF levels were below the limit of detection for both E2-CDS and E2-Q+, however, brain tissue concentrations of E2-Q+ were similar in several brain regions of individual animals examined 1 or 3 days after drug dosing. © 1990, Plenum Publishing Corporation. All rights reserved.
引用
收藏
页码:879 / 883
页数:5
相关论文
共 24 条
[1]   EVIDENCE FOR THE REESTABLISHMENT OF COPULATORY-BEHAVIOR IN CASTRATED MALE-RATS WITH A BRAIN-ENHANCED ESTRADIOL-CHEMICAL DELIVERY SYSTEM [J].
ANDERSON, WR ;
SIMPKINS, JW ;
BREWSTER, ME ;
BODOR, N .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1987, 27 (02) :265-271
[2]   IMPROVED DELIVERY THROUGH BIOLOGICAL-MEMBRANES .11. A REDOX CHEMICAL DRUG-DELIVERY SYSTEM AND ITS USE FOR BRAIN-SPECIFIC DELIVERY OF PHENYLETHYLAMINE [J].
BODOR, N ;
FARAG, HH .
JOURNAL OF MEDICINAL CHEMISTRY, 1983, 26 (03) :313-318
[3]   REDOX DELIVERY SYSTEM FOR BRAIN-SPECIFIC, SUSTAINED-RELEASE OF DOPAMINE [J].
BODOR, N ;
SIMPKINS, JW .
SCIENCE, 1983, 221 (4605) :65-67
[4]   IMPROVED DELIVERY THROUGH BIOLOGICAL-MEMBRANES .14. BRAIN-SPECIFIC, SUSTAINED DELIVERY OF TESTOSTERONE USING A REDOX CHEMICAL DELIVERY SYSTEM [J].
BODOR, N ;
FARAG, HH .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (03) :385-389
[5]   SITE-SPECIFIC, SUSTAINED-RELEASE OF DRUGS TO THE BRAIN [J].
BODOR, N ;
FARAG, HH ;
BREWSTER, ME .
SCIENCE, 1981, 214 (4527) :1370-1372
[6]  
Bodor N., 1983, PHARMACOL THERAPEUT, V19, P337
[7]  
BODOR N, 1985, METHODS ENZYMOLOGY D, P381
[8]  
BODOR N, 1985, DESIGN PRODRUGS, P333
[9]   METABOLISM OF ESTROGENS - NATURAL AND SYNTHETIC [J].
BOLT, HM .
PHARMACOLOGY & THERAPEUTICS, 1979, 4 (01) :155-181
[10]  
BRADBURY MW, 1989, IMPLICATIONS BLOOD B, P119